Log In
Friday 28th October 2016

New drug helps smokers quit

5th December 2006

A new drug, aimed at helping smokers to quit, has been made available in the UK.

The new treatment called, Varenicline (champix), is the first nicotine-free drug developed specifically to help smokers give up. The drug works by mimicking the effects of nicotine on the body and is thought to work by both reducing the urge to smoke and relieving withdrawal symptoms. The drug is due to be assessed by the National Institute for Clinical Excellence (NICE) next year.

Varenicline is produced by Pfizer and is unique in that it both stimulates and blocks specific nicotinic receptors in the brain. 44% of smokers who trialled the drug said they had stopped smoking after 12 weeks. The only known side-effect of the drug is said to be nausea but patients are being advised to report any side effects as the treatment is so new.

The drug, which costs just under £2 per day, is likely to be in heavy demand next year when the ban on smoking in public places in England comes into force in July.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016